Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Ceftriaxone
- Therapeutic area
- Anti-infectives
- Drug class
- Third-generation cephalosporins
- ATC
- J01DD04
- Strength
- 250 mg
- Dosage form
- Injection
- Pack
- Vial
- Registration no.
- 108041
- Price record verified
- 2026-08-24
- Latest DRAP source check
- 2026-09-28 02:57
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 156.36 to 164.09 (+4.9%) between 1 Jul 2025 and 17 Aug 2026 · 2 official price records · pack Vial
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Ceftigen 250 mg, Vial: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/ceftigen-250-mg-108041-vial-biogen-life-sciences/ (accessed 28 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 164.09 | 2026-08-17 | 2026-08-24 | DRAP PharmaPrice Index | Current |
| PKR 156.36 | 2025-07-01 | 2026-08-09 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 108041Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.
